{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:59:24Z","timestamp":1787731164225,"version":"build-2784847793"},"reference-count":25,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Anti-IH is a common cold agglutinin that is typically clinically insignificant. We present a case that resulted in hemolysis. A 32-year-old male patient with transfusion-independent beta-thalassemia intermedia presented with symptomatic anemia. His blood sample typed as group B, D+ and demonstrated multiple alloantibodies and cold autoantibodies. He was transfused uneventfully, but re-presented 10 days later with recurrent, worsening anemia. At this time, transfusion of group O, phenotype-matched red blood cells (RBCs) resulted in an acute hemolytic reaction. While anemia was initially attributed to drug-mediated bone marrow toxicit y and subsequently to a delayed hemolytic reaction, further evaluation revealed\n                    <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                    infection and a cold agglutinin (anti-IH specificity), indicating a likely autoimmune-mediated anemia due to an infectious etiology. Subsequent transfusion of 2 group B, phenotype-matched RBC units using a blood warmer was uneventful. Anti-IH is only rarely associated with hemolytic transfusion reactions, which may be exacerbated when transfusing group O RBC units to group B patients.\n                    <jats:italic>M. pneumoniae<\/jats:italic>\n                    infection likely led to cold agglutinin\u2013mediated hemolysis of endogenous and transfused RBCs. The patient was successfully managed with intravenous immunoglobulin, steroids, rituximab, erythropoietin, hydroxyurea, and amoxicillin clavulanate\/azithromycin. This case illustrates the importance of infectious disease evaluation in patients with unexplained anemia, the potential clinical significance of autoanti-IH, and the value of providing type-specific RBC units in these circumstances.\n                  <\/jats:p>","DOI":"10.2478\/immunohematology-2024-018","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T14:22:27Z","timestamp":1735654947000},"page":"139-144","source":"Crossref","is-referenced-by-count":2,"title":["Hemolysis due to anti-IH in a patient with beta-thalassemia and\n                    <i>Mycoplasma pneumoniae<\/i>\n                    infection"],"prefix":"10.2478","volume":"40","author":[{"given":"Jennifer N.","family":"Chousal","sequence":"first","affiliation":[{"name":"Department of Pathology, University of California San Diego , La Jolla , CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forough","family":"Sargolzaeiaval","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Diego , La Jolla , CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tridu R.","family":"Huynh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology-Oncology, University of California San Diego , La Jolla , CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Diego , La Jolla , CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Rodberg","sequence":"additional","affiliation":[{"name":"American Red Cross Reference Laboratory , Southern California, Pomona, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia M.","family":"Kopko","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Diego , La Jolla , CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srila","family":"Gopal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology-Oncology, University of California San Diego , La Jolla , CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S.","family":"Allen","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Diego , La Jolla , CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"key":"2026082406335345974_j_immunohematology-2024-018_ref_001","doi-asserted-by":"crossref","unstructured":"Klein H, Anstee D. Mollison\u2019s blood transfusion in clinical medicine. Malden, MA: Blackwell Publishing, 2005.","DOI":"10.1002\/9780470986868"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_002","unstructured":"van Buren NL. Autoimmune hemolytic anemias. In: Hillyer CD, Shaz BH, Abshire TC, Zimring JC, eds. Transfusion medicine and hemostasis: clinical and laboratory aspects. Amsterdam: Elsevier, 2009:1\u20131019."},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_003","doi-asserted-by":"crossref","unstructured":"Daniels G. Human blood groups. Oxford: Blackwell Science, 2002.","DOI":"10.1002\/9780470987018"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_004","doi-asserted-by":"crossref","unstructured":"Cooling L. An update on the I blood group system. Immunohematology 2019;35:85\u201390.","DOI":"10.21307\/immunohematology-2020-019"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_005","doi-asserted-by":"crossref","unstructured":"Berentsen S, Tj\u00f8nnfjord GE. Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. Blood Rev 2012;26107\u201315.","DOI":"10.1016\/j.blre.2012.01.002"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_006","doi-asserted-by":"crossref","unstructured":"Rosenfield R, Schroeder R, Ballard R, van der Hart M, Moes M, van Loghem J. Erythrocytic antigenic determinants characteristic of H, I in the presence of H (IH), or H in the absence of I (H(-I)). Vox Sang 1964;9:415\u20139.","DOI":"10.1159\/000464881"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_007","unstructured":"Berentsen S, Ma\u0142ecka A, Randen U, Tj\u00f8nnfjord GE. Cold agglutinin disease: where do we stand, and where are we going? Clin Adv Hematol Oncol 2020;18:35\u201344."},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_008","doi-asserted-by":"crossref","unstructured":"Berentsen S, D\u2019Sa S, Randen U, Malecka A, Vos JMI. Cold agglutinin disease: improved understanding of pathogenesis helps define targets for therapy. Hemato 2022;3:574\u201394.","DOI":"10.3390\/hemato3040040"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_009","unstructured":"Arndt P, Garratty G, Haverty D, McGrath C, Tobias P, Larison J. Clinically significant anti-HI in two patients with greatly increased I antigen on their red cells (abstract). Blood 1997;90(Suppl 1):472a."},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_010","doi-asserted-by":"crossref","unstructured":"Campbell S, Shirey R, King K, Ness P. An acute hemolytic transfusion reaction due to anti-IH in a patient with sickle cell disease. Transfusion 2000;40:828\u201331.","DOI":"10.1046\/j.1537-2995.2000.40070828.x"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_011","doi-asserted-by":"crossref","unstructured":"Darabi K, Makar RS. Acute hemolysis of transfused A2 red cells by an auto-HI antibody. Transfusion 2008;48:964\u20138.","DOI":"10.1111\/j.1537-2995.2008.01661.x"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_012","doi-asserted-by":"crossref","unstructured":"Irani MS, Richards C. Hemolytic transfusion reaction due to anti-IH. Transfusion 2011;51:2676\u20138.","DOI":"10.1111\/j.1537-2995.2011.03209.x"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_013","doi-asserted-by":"crossref","unstructured":"Ibanez C, Habibi A, Mekontso-Dessap A, et al. Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients. Transfusion 2016;56:1828\u201333.","DOI":"10.1111\/trf.13611"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_014","unstructured":"Read S, Witeoak E, Benjamin R. Unusual IH-like antibody implicated in delayed hemolytic transfusion reaction (abstract). Transfusion 2003;43(Suppl):101a."},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_015","doi-asserted-by":"crossref","unstructured":"Boonyasampant M, Weitz IC, Kay B, Boonchalermvichian C, Liebman HA, Shulman I A. Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab. Transfusion 2015;55:2398\u2013403.","DOI":"10.1111\/trf.13144"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_016","doi-asserted-by":"crossref","unstructured":"Win N, Yeghen T, Needs M, Chen FE, Okpala I. Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease. Hematology 2004;9:433\u20136.","DOI":"10.1080\/10245330400001926"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_017","doi-asserted-by":"crossref","unstructured":"Algiraigri AH, Wright NA, Kassam A. Hydroxyurea for \u03b2-Thalassemia Major: A Meta-Analysis. Blood 2014;124:4894.","DOI":"10.1182\/blood.V124.21.4894.4894"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_018","doi-asserted-by":"crossref","unstructured":"Musia\u0142ek MW, Rybaczek D. Hydroxyurea\u2014the good, the bad and the ugly. Genes 2021;12:1096. doi:10.3390\/genes12071096.","DOI":"10.3390\/genes12071096"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_019","doi-asserted-by":"crossref","unstructured":"Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 2008;32:956\u201373.","DOI":"10.1111\/j.1574-6976.2008.00129.x"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_020","unstructured":"Zhang L, Zong Z-Y, Liu Y-B, Ye H, Ly X-J. PCR versus serology for diagnosing Mycoplasma pneumoniae infection: a systematic review & meta-analysis. Indian J Med Res 2011; 134:270\u201380."},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_021","doi-asserted-by":"crossref","unstructured":"Loens K, Goossens H, Leven M. Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods. Eur J Clin Microbiol Infect Dis 2010;29:1055\u201369.","DOI":"10.1007\/s10096-010-0975-2"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_022","doi-asserted-by":"crossref","unstructured":"Hamblin T. Management of cold agglutination syndrome. Transfus Sci 2000;22:121\u20134.","DOI":"10.1016\/S0955-3886(00)00032-1"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_023","doi-asserted-by":"crossref","unstructured":"Petz LD. Cold antibody autoimmune hemolytic anemias. Blood Rev 2008;22:1\u201315.","DOI":"10.1016\/j.blre.2007.08.002"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_024","doi-asserted-by":"crossref","unstructured":"Packman CH. The clinical pictures of autoimmune hemolytic anemia. Transfus Med Hemother 2015;42:317\u201324. doi:10.1159\/000440656.","DOI":"10.1159\/000440656"},{"key":"2026082406335345974_j_immunohematology-2024-018_ref_025","doi-asserted-by":"crossref","unstructured":"Berentsen S, Fattizzo B, Barcellini W. The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket? Front Immunol 2023;14:1180509. doi:10.3389\/fimmu.2023.1180509.","DOI":"10.3389\/fimmu.2023.1180509"}],"container-title":["Immunohematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/immunohematology-2024-018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:34:03Z","timestamp":1787553243000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/immunohematology-2024-018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,12,31]]},"published-print":{"date-parts":[[2024,12,1]]}},"alternative-id":["10.2478\/immunohematology-2024-018"],"URL":"https:\/\/doi.org\/10.2478\/immunohematology-2024-018","relation":{},"ISSN":["1930-3955"],"issn-type":[{"value":"1930-3955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}